PATENT CLAIM ANALYSIS

Application Number: 15747157
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "054000"]

Abstract:
Disclosed are ophthalmic formulations which use complexes called L/H-HA, obtainable by subjecting at least two fractions of hyaluronic acids and/or other glycosaminoglycans with different molecular weights to an appropriate heat cycle.

Claim (Index 8):
Ophthalmic formulations according to  claim 1  comprising other active ingredients for ophthalmic use, buffering agents, salts, osmolarity adjusting agents, preservatives, lenitives and rheological agents.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 86.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14974657', '10484241', '12063623', '12681256', '13147153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7310751805244908
- 35 USC 102 Novelty (BERT): 0.4741356413215589
- Combined Prediction Score: 0.7053812266041977
- Mean Citation Score: 156.149132
- Max Citation Score: 179.60078
- Similarity Product: 137.77820926403402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test